Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SOLENO THERAPEUTICS INC | Sr. VP of Clinical Development | Common Stock | 36.8K | $2.58M | $70.03 | Mar 27, 2025 | Direct |
SOLENO THERAPEUTICS INC | Sr. VP of Clinical Development | Employee stock option (right to buy) | 110K | Mar 27, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SLNO | SOLENO THERAPEUTICS INC | Mar 27, 2025 | 11 | -$794K | 4 | Mar 31, 2025 | Sr. VP of Clinical Development |
SLNO | SOLENO THERAPEUTICS INC | Jan 21, 2025 | 2 | $0 | 4 | Jan 23, 2025 | Sr. VP of Clinical Development |
SLNO | SOLENO THERAPEUTICS INC | Jul 17, 2024 | 1 | $0 | 4 | Jul 19, 2024 | Sr. VP of Clinical Development |
SLNO | SOLENO THERAPEUTICS INC | Apr 22, 2024 | 0 | $0 | 3 | Apr 30, 2024 | Sr. VP of Clinical Development |